$2.49
+0.34 (+15.81%)
Open$2.11
Previous Close$2.15
Day High$2.49
Day Low$2.10
52W High$9.37
52W Low$1.63
Volume—
Avg Volume25.9K
Market Cap7.85M
P/E Ratio—
EPS$-1.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+82.3% upside
Current
$2.49
$2.49
Target
$4.54
$4.54
$3.16
$4.54 avg
$6.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.11M | 7.07M | 1.27M |
| Net Income | -9,930,353 | -7,790,548 | 357.5K |
| Profit Margin | -122.5% | -116.3% | 28.2% |
| EBITDA | -10,235,780 | -8,476,282 | 531.9K |
| Free Cash Flow | — | — | 275.9K |
| Rev Growth | +14.7% | +14.7% | -7.0% |
| Debt/Equity | — | — | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |